These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29268403)

  • 1. Comparison of clinical and radiological characteristics between anaplastic lymphoma kinase rearrangement and epidermal growth factor receptor mutation in treatment naïve advanced lung adenocarcinoma.
    Miao Y; Zhu S; Li H; Zou J; Zhu Q; Lv T; Song Y
    J Thorac Dis; 2017 Oct; 9(10):3927-3937. PubMed ID: 29268403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of
    Lv Z; Fan J; Xu J; Wu F; Huang Q; Guo M; Liao T; Liu S; Lan X; Liao S; Geng W; Jin Y
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):735-750. PubMed ID: 29164298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced adenocarcinoma of the lung: comparison of CT characteristics of patients with anaplastic lymphoma kinase gene rearrangement and those with epidermal growth factor receptor mutation.
    Choi CM; Kim MY; Hwang HJ; Lee JB; Kim WS
    Radiology; 2015 Apr; 275(1):272-9. PubMed ID: 25575117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and computed tomography characteristics of non-small cell lung cancer with ALK gene rearrangement: Comparison with EGFR mutation and ALK/EGFR-negative lung cancer.
    Mori M; Hayashi H; Fukuda M; Honda S; Kitazaki T; Shigematsu K; Matsuyama N; Otsubo M; Nagayasu T; Hashisako M; Tabata K; Uetani M; Ashizawa K
    Thorac Cancer; 2019 Apr; 10(4):872-879. PubMed ID: 30811109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT.
    Choi H; Paeng JC; Kim DW; Lee JK; Park CM; Kang KW; Chung JK; Lee DS
    Lung Cancer; 2013 Mar; 79(3):242-7. PubMed ID: 23261227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between 18F-FDG PET/CT radiometabolic markers and EGFR mutation, positive ALK Expression in patients with non-small cell lung cancer.
    Gayaf M; Anar C; Aksel N; Erbaycu AE; Koporal H
    Tuberk Toraks; 2021 Dec; 69(4):437-448. PubMed ID: 34957737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of serum tumor markers for predicting EGFR mutations and positive ALK expression in 1089 Chinese non-small-cell lung cancer patients: A retrospective analysis.
    Wang S; Ma P; Ma G; Lv Z; Wu F; Guo M; Li Y; Tan Q; Song S; Zhou E; Geng W; Duan Y; Li Y; Jin Y
    Eur J Cancer; 2020 Jan; 124():1-14. PubMed ID: 31707279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed Tomography Imaging Characteristics of Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements: A Systematic Review and Meta-Analysis.
    Mendoza DP; Stowell J; Muzikansky A; Shepard JO; Shaw AT; Digumarthy SR
    Clin Lung Cancer; 2019 Sep; 20(5):339-349. PubMed ID: 31164317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of imaging biomarkers in predicting anaplastic lymphoma kinase-positive lung adenocarcinoma.
    Jeong CJ; Lee HY; Han J; Jeong JY; Lee KS; Choi YL; Choi JY
    Clin Nucl Med; 2015 Jan; 40(1):e34-9. PubMed ID: 25243942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements in lung cancer with nodular ground-glass opacity.
    Ko SJ; Lee YJ; Park JS; Cho YJ; Yoon HI; Chung JH; Kim TJ; Lee KW; Kim K; Jheon S; Kim H; Lee JH; Lee CT
    BMC Cancer; 2014 May; 14():312. PubMed ID: 24885886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of FDG PET/CT, tumor markers and Ki-67 index with EGFR mutation or positive ALK expression in patients with non-small cell lung cancer.
    Wang HC; Wang ZM; Hu WD; Liang XQ; Cui LL
    Q J Nucl Med Mol Imaging; 2024 Jul; ():. PubMed ID: 39008330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are there imaging characteristics associated with lung adenocarcinomas harboring ALK rearrangements?
    Halpenny DF; Riely GJ; Hayes S; Yu H; Zheng J; Moskowitz CS; Ginsberg MS
    Lung Cancer; 2014 Nov; 86(2):190-4. PubMed ID: 25312988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and CT characteristics of surgically resected lung adenocarcinomas harboring ALK rearrangements or EGFR mutations.
    Wang H; Schabath MB; Liu Y; Han Y; Li Q; Gillies RJ; Ye Z
    Eur J Radiol; 2016 Nov; 85(11):1934-1940. PubMed ID: 27776643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of clinicoradiologic characteristics of lung adenocarcinomas with ALK rearrangements or EGFR mutations.
    Zhou JY; Zheng J; Yu ZF; Xiao WB; Zhao J; Sun K; Wang B; Chen X; Jiang LN; Ding W; Zhou JY
    Eur Radiol; 2015 May; 25(5):1257-66. PubMed ID: 25577516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between EGFR, ALK Gene Mutation and Imaging 
and Pathological Features in Invasive Lung Adenocarcinoma].
    Yang H; Liu Z; Wang H; Chen L; Wang J; Wen W; Xu X; Zhu Q
    Zhongguo Fei Ai Za Zhi; 2022 Mar; 25(3):147-155. PubMed ID: 35340157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Gamma Knife Radiosurgery for Brain Metastases From Anaplastic Lymphoma Kinase Rearrangement-Positive and EGFR Mutation-Positive Non-Small Cell Lung Cancer.
    Matsunaga S; Shuto T
    Cureus; 2021 Dec; 13(12):e20398. PubMed ID: 35047245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between combining
    Ruan M; Liu L; Wang L; Lei B; Sun X; Chang C; Shen Y; Xie W
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1183-1197. PubMed ID: 31897590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant EGFR Mutation and EML4-ALK Rearrangement in Lung Adenocarcinoma Is More Frequent in Multifocal Lesions.
    Fan J; Dai X; Wang Z; Huang B; Shi H; Luo D; Zhang J; Cai W; Nie X; Hirsch FR
    Clin Lung Cancer; 2019 Jul; 20(4):e517-e530. PubMed ID: 31138506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between serum tumor markers and Anaplastic Lymphoma Kinase mutations in stage IV lung adenocarcinoma in Hubei province, Central China.
    Tan Q; Huang Q; Ma G; Lv Z; Mei P; Mao K; Wu F; Jin Y
    J Clin Lab Anal; 2020 Jan; 34(1):e23027. PubMed ID: 31489711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of synchronous multiple primary lung adenocarcinomas harboring epidermal growth factor receptor mutation and anaplastic lymphoma kinase rearrangement successfully treated with combination of osimertinib and alectinib.
    Inoue Y; Matsubara O; Ohira Y; Endo S; Jinn Y
    Respir Med Case Rep; 2021; 33():101418. PubMed ID: 34401266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.